— Know what they know.
Not Investment Advice

TXN vs ARM vs KLAC

161 measures in 16 categories, one definition each, computed from filings and market data.
TXN78.6
Texas Instruments Incorporated
Technology · Semiconductors
$276.48 −0.95%$252.5B mkt cap
Score DNA
ARM79.9
Arm Holdings plc American Depositary Shares
Technology · Semiconductors
$227.80 −6.94%$243.3B mkt cap
Score DNA
KLAC72.1
KLA Corporation
Technology · Semiconductors
$165.74 −5.00%$216.3B mkt cap
Score DNA

Price, rebased to 100 three years ago

TXN   ARM   KLAC   · weekly adjusted closes
50100150200250300350400450500550600650700750800850Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26ARM 449KLAC 349TXN 197
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureTXNARMKLAC
Insider open-market buys, 180d 0 0 0
Insider $ bought, 180d — — —
Congress purchases, 180d 2 0 3
Last Congress purchase 2026-07-07 — 2026-09-23
13F net change in holders +413 +218 +413
ETFs adding shares, 30d 1,895 230 1,859
ETFs trimming, 30d 1,533 151 1,478
Net ETF funds, 30d +362 +79 +381

Valuation

16 measures
MeasureTXNARMKLAC
P/E (TTM) 41.7x
39th
233.0x
94th
44.8x
47th
PEG (P/E ÷ 3-yr EPS CAGR) — — —
Price / sales 13.0x
71st
47.2x
97th
15.9x
79th
Price / book 14.0x
84th
28.2x
97th
34.1x
100th
Price / tangible book 20.5x
73rd
56.3x
93rd
92.4x
97th
Price / free cash flow 47.2x
43rd
165.1x
87th
57.4x
50th
Price / operating cash flow 29.1x
34th
116.2x
93rd
52.2x
67th
Enterprise value $259.5B
91st
$239.9B
89th
$217.5B
88th
EV / sales 13.3x
71st
46.5x
100th
16.0x
79th
EV / EBITDA 26.8x
44th
174.7x
92nd
35.9x
59th
EV / EBIT 34.7x
38th
216.3x
96th
38.4x
51st
EV / free cash flow 48.5x
43rd
162.7x
89th
57.7x
52nd
Earnings yield 2.4%
73rd
0.4%
36th
2.2%
68th
FCF yield 2.1%
69th
0.6%
37th
1.7%
64th
Operating cash flow yield 3.4%
73rd
0.9%
28th
1.9%
48th
Graham number (per share) $53.82
75th
$13.21
15th
$19.91
23rd

Profitability (TTM)

12 measures
MeasureTXNARMKLAC
Gross margin 58.3%
77th
95.3%
100th
61.3%
84th
EBITDA margin 49.7%
92nd
26.6%
65th
44.6%
91st
Operating margin 37.3%
93rd
17.3%
68th
41.7%
95th
EBIT margin 38.4%
92nd
21.5%
69th
41.7%
95th
Net margin 31.1%
89th
20.2%
71st
35.6%
95th
NOPAT margin 32.7%
92nd
14.3%
64th
35.9%
95th
FCF margin 27.5%
84th
28.6%
89th
27.7%
87th
Operating cash flow margin 44.6%
95th
40.6%
91st
30.5%
84th
R&D / revenue 10.7%
27th
57.5%
92nd
11.3%
28th
SG&A / revenue 9.5%
25th
21.0%
73rd
8.3%
20th
Stock comp / revenue 2.8%
40th
22.4%
93rd
2.3%
33rd
Effective tax rate 12.4%
23rd
17.4%
51st
13.8%
33rd

Returns on capital

11 measures
MeasureTXNARMKLAC
ROE (on average equity) 35.2%
91st
13.4%
65th
87.5%
97th
ROA 17.1%
83rd
10.1%
71st
28.4%
95th
ROIC 25.4%
77th
14.1%
60th
64.2%
92nd
ROCE 22.9%
85th
11.1%
67th
41.5%
96th
Return on tangible assets 21.1%
84th
10.8%
67th
33.3%
95th
Cash ROIC (OCF / invested capital) 34.6%
79th
40.1%
86th
54.5%
96th
Gross profitability (GP / assets) 31.6%
68th
43.9%
91st
46.4%
93rd
ROIC, 3-yr average 24.2%
80th
15.3%
69th
80.7%
98th
ROIC, 5-yr average 38.8%
83rd
— 1,581.4%
100th
ROE, 5-yr average 40.9%
92nd
— 119.5%
100th
Incremental ROIC 120.2%
86th
9.3%
44th
80.1%
80th

Growth

17 measures
MeasureTXNARMKLAC
Revenue growth (TTM YoY) 16.7%
47th
25.1%
63rd
11.7%
38th
Revenue growth (QoQ) 13.2%
49th
-13.5%
0th
7.1%
21st
Revenue CAGR, 3 yr 1.1%
41st
— 9.0%
64th
Revenue CAGR, 5 yr 3.0%
30th
— 14.4%
71st
Gross profit CAGR, 3 yr -3.1%
33rd
— 9.9%
61st
Operating income CAGR, 3 yr -6.1%
40th
— 12.3%
68th
Net income growth (TTM YoY) 20.1%
37th
49.4%
61st
18.9%
34th
Net income CAGR, 3 yr -7.7%
44th
— 12.6%
67th
EPS growth (TTM YoY) 19.0%
34th
47.6%
61st
19.6%
37th
EPS CAGR, 3 yr -7.8%
44th
— -47.0%
8th
EPS CAGR, 5 yr -1.7%
29th
— -22.9%
15th
FCF growth (TTM YoY) 256.3%
91st
124.4%
87th
0.6%
35th
FCF CAGR, 3 yr 18.9%
68th
— 4.2%
51st
Operating cash flow CAGR, 3 yr 5.6%
58th
— 4.1%
52nd
Book value CAGR, 3 yr 4.0%
36th
— -39.0%
1st
Dividend CAGR, 3 yr 1.3%
33rd
— -50.4%
0th
Sustainable growth rate 5.5%
29th
13.4%
56th
68.3%
96th

Margin history & stability

7 measures
MeasureTXNARMKLAC
Gross margin, 3-yr average 58.6%
81st
94.4%
100th
60.9%
85th
Operating margin, 3-yr average 36.4%
94th
13.7%
61st
40.4%
97th
Net margin, 3-yr average 31.5%
93rd
16.4%
72nd
32.4%
94th
FCF margin, 3-yr average 15.3%
61st
22.1%
77th
29.8%
93rd
Revenue stability (0-1) 0.13
17th
0.98
97th
0.92
86th
Earnings stability (0-1) 0.40
56th
1.00
100th
0.73
81st
Margin stability (0-1) 0.93
56th
0.99
97th
0.99
99th

Liquidity (latest quarter)

7 measures
MeasureTXNARMKLAC
Cash & short-term investments $7.0B
91st
$3.9B
84th
$4.9B
87th
Net cash (− = net debt) −$7.1B
4th
$3.4B
96th
−$1.2B
15th
Working capital $12.5B
92nd
$5.1B
83rd
$8.1B
87th
Current ratio 4.86
65th
5.25
72nd
2.88
37th
Quick ratio 3.44
61st
5.25
79th
2.03
37th
Cash ratio (cash + ST investments / current liabilities) 2.16
61st
3.22
69th
1.14
33rd
Defensive interval (days) 849 days
56th
534 days
31st
1,109 days
69th

Leverage & solvency (latest quarter)

13 measures
MeasureTXNARMKLAC
Total debt $14.1B
95th
$485.0M
56th
$6.2B
89th
Debt / equity 0.78
84th
0.06
39th
0.97
91st
Net debt / equity 0.39
87th
−0.39
27th
0.20
77th
Debt / assets 39.2%
87th
4.3%
40th
34.3%
83rd
Debt / capital 43.8%
84th
5.3%
39th
49.2%
91st
Debt / EBITDA 1.45
60th
0.35
32nd
1.02
44th
Net debt / EBITDA 0.73
80th
−2.48
26th
0.21
72nd
Interest coverage (EBIT / interest) 13.2x
52nd
— 19.9x
65th
Cash interest coverage 15.4x
50th
— 14.6x
48th
Debt payback (years of OCF) 1.6 yrs
57th
0.2 yrs
24th
1.5 yrs
55th
Liabilities / assets 49.8%
79th
22.9%
37th
64.6%
95th
IS credit model rating AA AA AA
Implied credit spread (bps) 80
19th
80
19th
80
19th

Efficiency

11 measures
MeasureTXNARMKLAC
Asset turnover 0.55
55th
0.50
41st
0.80
85th
Fixed asset turnover 1.63
13th
3.71
37th
9.84
87th
Inventory turnover 1.7
14th
— 1.5
10th
Receivables turnover 8.7
76th
4.2
17th
5.3
32nd
Days sales outstanding 42 days
24th
86 days
83rd
69 days
68th
Days inventory outstanding 212 days
86th
— 238 days
90th
Days payables outstanding 35 days
16th
94 days
89th
38 days
23rd
Cash conversion cycle (days) 219 days
84th
−7 days
1st
270 days
93rd
Capex / revenue 17.0%
89th
12.0%
81st
2.8%
28th
Capex / depreciation 1.50
76th
2.35
86th
0.95
54th
Operating expense ratio 19.1%
22nd
89.6%
93rd
18.9%
20th

Cash flow & earnings quality

7 measures
MeasureTXNARMKLAC
Operating cash flow / net income 1.43
56th
2.01
67th
0.86
23rd
FCF / net income 0.88
50th
1.41
79th
0.78
44th
FCF / operating cash flow 61.8%
32nd
70.4%
40th
90.9%
88th
Capex / operating cash flow 38.2%
68th
29.6%
60th
9.1%
12th
Accruals ratio -7.4%
27th
-10.2%
15th
4.0%
89th
Sloan accruals ratio -4.8%
16th
7.1%
61st
6.3%
60th
Earnings quality score (0-1) 0.75
15th
0.75
15th
0.75
15th

Dividends & buybacks

9 measures
MeasureTXNARMKLAC
Dividend yield 2.1%
93rd
0.0%
0th
0.5%
76th
Dividend per share (TTM) $5.68
99th
$0.00
0th
$0.84
81st
Payout ratio (dividends / net income) 84.5%
88th
0.0%
0th
21.9%
69th
Dividends / FCF 95.5%
89th
0.0%
0th
28.1%
74th
Dividend growth (YoY) 3.4%
44th
— 17.6%
81st
Buyback yield 0.3%
63rd
0.1%
49th
1.1%
80th
Shareholder yield (dividends + buybacks) 2.3%
81st
0.1%
37th
1.5%
71st
Share count change (YoY) 0.9%
37th
1.2%
42nd
-0.6%
16th
Buybacks, last 5 years $6.6B
88th
$1.1B
76th
$10.7B
92nd

Scores & forensic checks

15 measures
MeasureTXNARMKLAC
IS score 79
88th
80
93rd
72
73rd
IS profitability 95
91st
62
68th
98
95th
IS growth 69
49th
77
74th
71
58th
IS value 39
64th
36
44th
40
69th
IS momentum 92
77th
100
95th
76
44th
IS risk (safety) 100
12th
100
12th
100
12th
IS quality 88
95th
84
83rd
80
71st
IS balance sheet 84
47th
93
80th
84
44th
IS earnings quality 72
81st
55
33rd
57
36th
IS cash flow 79
83rd
92
96th
67
63rd
Piotroski F-score (0-9) 7
65th
7
65th
7
65th
Altman Z-score 12.9
55th
91.3
97th
23.2
72nd
Beneish M-score −3.06
8th
−2.98
11th
−2.03
70th
Ohlson O-score −10.03
37th
−11.81
15th
−8.99
55th
IS credit score 86
64th
90
76th
87
67th

Per share

7 measures
MeasureTXNARMKLAC
EPS, diluted (TTM) $6.58
83rd
$0.97
47th
$3.66
77th
Book value per share $19.57
56th
$8.01
23rd
$4.81
8th
Tangible book per share $14.65
61st
$6.37
31st
$3.28
23rd
Revenue per share $21.14
65th
$4.78
19th
$10.29
39th
FCF per share $5.82
88th
$1.37
45th
$2.85
72nd
Operating cash flow per share $9.42
89th
$1.94
43rd
$3.14
63rd
Cash per share $7.61
59th
$3.61
17th
$3.71
19th

Size (TTM)

8 measures
MeasureTXNARMKLAC
Market cap $252.5B
91st
$243.3B
89th
$216.3B
88th
Revenue $19.5B
89th
$5.2B
76th
$13.6B
85th
EBITDA $9.7B
92nd
$1.4B
75th
$6.1B
88th
Net income $6.1B
91st
$1.0B
81st
$4.8B
89th
Free cash flow $5.4B
92nd
$1.5B
80th
$3.8B
88th
Total assets $35.9B
89th
$11.2B
75th
$18.0B
81st
Shareholders' equity $18.0B
88th
$8.6B
80th
$6.3B
75th
Employees 33,000
89th
9,584
72nd
17,100
77th

Price performance

9 measures
MeasureTXNARMKLAC
1 day −0.9% −6.9% −5.0%
1 week −2.6% −14.4% −15.2%
1 month +7.1% −14.0% −1.9%
3 months −2.2% −15.5% −20.1%
6 months +21.5% +36.6% −7.3%
Year to date +58.4% +98.5% +30.5%
1 year +61.8% +33.5% +53.3%
3 years, cumulative +91.5% +316.6% +251.7%
5 years, cumulative +63.2% — +433.8%

Technicals

4 measures
MeasureTXNARMKLAC
RSI 14 47.6 34.5 31.1
From 52-week high −16.8% −49.7% −46.0%
From 52-week low +84.1% +127.8% +55.2%
Beta 1.34 3.79 1.45
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms